Research Briefs: Medtronic’s New Renal Denervation Trial; CPAP Combats Hypertension; Prosigna Breast Cancer Assay
This article was originally published in The Gray Sheet
Executive Summary
Medtronic launches the SYMPLICITY HTN-4 trial in moderate hypertension patients. Trial shows CPAP for sleep-apnea patients can also improve blood pressure. The information provided by NanoString’s breast cancer assay could help patients avoid unnecessary chemotherapy.